Supplemental material
OncoImmunology
Volume 8, 2019 - Issue 9
Open access
2,377
Views
20
CrossRef citations to date
0
Altmetric
Original Research
A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer
L. FaucheuxInstitut Curie, PSL Research University, Paris, France;Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, FranceView further author information
, M. GrandclaudonInstitut Curie, PSL Research University, Paris, France;Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, FranceView further author information
, M. Perrot-DockèsInstitut Curie, PSL Research University, Paris, France;Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, FranceView further author information
, P. SirvenInstitut Curie, PSL Research University, Paris, France;Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, FranceView further author information
, F. BergerInstitut Curie, PSL Research University, Paris, France;U900, Unit of biometry, INSERM, Paris, Francehttps://orcid.org/0000-0002-3251-4060View further author information
, A.S. HamyInstitut Curie, PSL Research University, Paris, France;Departement of translational research, Residual tumor and response to treatment laboratory (RT2Lab), UMR 932 Immunity and Cancer, INSERM, Paris, Francehttps://orcid.org/0000-0003-4430-3022View further author information
, V. FourchotteDepartement of Surgical Oncology, Institut Curie, Paris, FranceView further author information
, A. Vincent-SalomonDiagnostic and Theranostic medicine division, Institut Curie, Paris, France;Department of Biopathology, U934, INSERM, Paris, FranceView further author information
, F. Mechta-GrigoriouInstitut Curie, PSL Research University, Paris, France;Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, FranceView further author information
, F. ReyalInstitut Curie, PSL Research University, Paris, France;Departement of translational research, Residual tumor and response to treatment laboratory (RT2Lab), UMR 932 Immunity and Cancer, INSERM, Paris, France;Departement of Surgical Oncology, Institut Curie, Paris, Francehttps://orcid.org/0000-0002-2318-3589View further author information
, A. Scholer-DahirelInstitut Curie, PSL Research University, Paris, France;Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, FranceView further author information
, M. Guillot-DelostInstitut Curie, PSL Research University, Paris, France;Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, France;Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, FranceView further author information
& V. SoumelisInstitut Curie, PSL Research University, Paris, France;Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, France;Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, FranceCorrespondence[email protected]
View further author information
show allView further author information
Article: e1624130
|
Received 26 Feb 2019, Accepted 18 May 2019, Published online: 24 Jun 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.